Selenomethionine Improves Mitochondrial Function by Upregulating Mitochondrial Selenoprotein in a Model of Alzheimer’s Disease

Alzheimer’s disease (AD), the most common neurodegenerative disease in elderly humans, is pathologically characterized by amyloid plaques and neurofibrillary tangles. Mitochondrial dysfunction that occurs in the early stages of AD, which includes dysfunction in mitochondrial generation and energy me...

Повний опис

Бібліографічні деталі

Автори:	Chen Chen, Yao Chen, Zhong-Hao Zhang, Shi-Zheng Jia, Yu-Bin Chen, Shao-Ling Huang, Xin-Wen Xu, Guo-Li Song
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Frontiers Media S.A. 2021-10-01
Серія:	Frontiers in Aging Neuroscience
Предмети:	selenomethionine mitochondrial selenoprotein Alzheimer’s disease mitochondria dysfunction and dementia therapeutic effect and mechanism
Онлайн доступ:	https://www.frontiersin.org/articles/10.3389/fnagi.2021.750921/full
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!